- Home
- Media centre
- News features
- Developing world
Our commitment to the developing world
Press release: 20 January 2010
20 January 2010: Andrew Witty, during a speech at the Council on Foreign Relations, announced an ‘open innovation’ strategy to help deliver new and better medicines for people living in the world’s poorest countries.
For more information, please read the press release, available in six languages:
Transcript of speech to the Council on Foreign Relations
Referring to a speech given at the Council on Foreign Relations in New York on 20 January 2010, Mr Witty said,“We want to be a company that is truly a partner in addressing the healthcare challenges in the world's poorest countries, no matter how difficult they are. A restless company, never satisfied with what it has achieved, but always looking for ways of doing more."
Development of the candicate malaria vaccine
GSK has made a pledge to create a sustainable pricing model for the world’s most advanced malaria candidate vaccine.
Malaria-related press releases
- 3 Nov 2009: World’s largest malaria vaccine trial now underway in seven African countries
- 8 Dec 2008: Two new studies in the New England Journal of Medicine show malaria vaccine candidate advancing in Africa
- 29 Feb 2008: Update on GSK's malaria treatments: Dacart and Lapdap
- 24 Jan 2008: GlaxoSmithKline and Medicines For Malaria Venture announce new collaboration to investigate novel antimalarial compounds
Andrew Witty's Harvard speech: 13 February 2009
Policy on pricing for Least Developed Countries
On 13 February 2009, Andrew Witty announced that GSK would reduce its prices for patented medicines in Least Developed Countries (LDCs) so they are no higher than 25% of the price in the developed world providing this covers the cost of goods.
Multimedia
Map
B-roll
Images
1st child vaccinated in Phase III RTS,S trials with Dr. Salim Abdulla, Principal Investigator.
Nurse vaccinating child in Phase II RTS,S trial.
Trial participant's mother sets up mosquito netting to protect her child against malaria.
Andrew Witty meets malaria trial participants at the Kombewa District Hospital in Kisumu, Kenya during July 2009.
Andrew Witty meets malaria trial participants at the Kombewa District Hospital in Kisumu, Kenya during July 2009.
Andrew Witty meets malaria trial participants at the Kombewa District Hospital in Kisumu, Kenya during July 2009.
Links
External links:
GSK-related links:
